Shanghai Universal Biotech Co.,Ltd. (SHE:301166)
China · Delayed Price · Currency is CNY 26.63
+0.83 (3.22%)
At close: Aug 4, 2026
SHE:301166 Market Cap
SHE:301166 has a market cap or net worth of 2.27 billion as of August 4, 2026. Its market cap has decreased by -21.79% in one year.
Market Cap
2.27B
Enterprise Value
1.14B
Revenue
1.13B
Ranking
n/a
PE Ratio
n/a
Stock Price
26.63
ChartMarket Cap Chart
Since December 28, 2021, SHE:301166's market cap has decreased from 9.10B to 2.27B, a decrease of -75.06%. That is a compound annual growth rate of -26.05%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2026 | 2.27B | -10.80% |
| Dec 31, 2025 | 2.54B | 3.97% |
| Dec 31, 2024 | 2.45B | -26.49% |
| Dec 29, 2023 | 3.33B | -15.99% |
| Dec 30, 2022 | 3.96B | -55.60% |
| Dec 31, 2021 | 8.93B | -1.94% |
| Dec 28, 2021 | 9.10B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Shenzhen Bioeasy Biotechnology | 2.58B |
| Landfar Bio-medicine | 2.57B |
| Shanghai Model Organisms Center | 2.55B |
| Yantai Zhenghai Biotechnology | 2.54B |
| Novoprotein Scientific | 2.47B |
| Shandong Sito Bio-technology | 2.32B |
| Suzhou Fushilai Pharmaceutical | 2.17B |
| Jilin Jian Yisheng Pharmaceutical | 2.14B |